Articles from ForSight Robotics

ForSight Robotics, a global pioneer in robotic eye surgery, today announced a significant milestone in the clinical evolution of ophthalmic robotics, demonstrating that fully robotic-assisted cataract surgery can be successfully integrated into the standard clinical workflow of the world's most commonly performed surgical procedure.

ForSight Robotics, the pioneer in ophthalmic robotic surgery, announced today it completed a $125M Series B round, led by Eclipse. The investment accelerates the next growth phase for the ORYOM™ Platform, the world’s first robotic surgery platform for cataract and other eye diseases designed to enhance surgical precision, increase patient access to high-quality treatment, and decrease the physical burden on surgeons, as the company prepares to launch first-in-human clinical trials this year. In addition to Eclipse, the funding round included significant participation from an undisclosed strategic investor, as well as Dr. Fred Moll, the Adani Group, Reiya Ventures, and other existing investors – bringing ForSight Robotics’ total funding to $195M.

ForSight Robotics, the pioneer in ophthalmic robotic surgery, announced today its achievement of ISO 13485:2016 certification, an international benchmark for quality management systems in the medical device industry. By achieving this certification, ForSight demonstrates its commitment to designing, developing and manufacturing a robotic surgical system and microscope intended for use in ophthalmic surgical procedures.

ForSight Robotics, the pioneer in ophthalmic robotic surgery, announced today that Dr. Fred Moll, the founder of Intuitive Surgical, has joined its Board of Directors. Intuitive Surgical is the company behind the da Vinci surgical system, the first robotic surgical platform commercially available in the U.S. to be cleared by the FDA for use in general laparoscopic surgery. His appointment to the Board of Directors marks his first advisor role for an ophthalmology-focused surgical robotics company.

ForSight Robotics, a pioneer of robotic eye surgery, announced today the appointment of Sharon Levita as Chief Financial Officer (CFO), effective September 1, 2023. Levita will lead ForSight Robotics’ strategic and financial operations, focusing on driving business strategies, expanding strategic partnerships, and managing financial and growth objectives.

ForSight Robotics, a pioneer of robotic eye surgery, today was recognized as a finalist in the Health category of Fast Company’s 2023 World Changing Ideas Awards. The prestigious list showcases some of the world’s most innovative projects and companies that are actively tackling global challenges.